About RecurX Bio
RecurX Bio was a Healthcare company based in Baltimore (United States) founded in 2020. It delivers comprehensive preclinical services for oncology drug development. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Drug Development and Preclinical Services. Its competitors include AlphaVax, DXOCRO and Cancer Research For Oza Rks.
Company details
RecurX Bio, founded in 2020 in Baltimore, United States, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and preclinical services. Delivers comprehensive preclinical services for oncology drug development. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Baltimore, United States
- SectorsHealthcare
- Website recurxbio.com
Competitors of RecurX Bio
RecurX Bio has 3 listed competitors in our database. They include AlphaVax, DXOCRO and Cancer Research For Oza Rks.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alphavax.com | 1997 | Durham, United States | Vaccines for infectious diseases and cancer immunotherapy are developed. | |||
| dxocro.com | 2017 | Oxford, United States | Provides in vitro diagnostic services for oncology research and development. | |||
| ozarkscancerresearch.org | 1987 | Springfield, United States | Clinical trials and research services for oncology drugs are provided. |
Detailed competitors of RecurX Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as RecurX Bio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RecurX Bio
RecurX Bio was founded in 2020.
RecurX Bio is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
RecurX Bio, founded in 2020 in Baltimore, United States, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and preclinical services. Delivers comprehensive preclinical services for oncology drug development. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
RecurX Bio's top competitors include AlphaVax, Cancer Research For Oza Rks and DXOCRO.